+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics

  • ID: 4805177
  • Report
  • February 2022
  • Region: Global
  • 664 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • 3M
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc
  • Cepheid Inc
  • Eiken Chemical Co., Ltd.
  • NEOGEN Corporation

Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026


Clinical microbiology holds a prominent role in the field of research and medicine, and support the fight against numerous infectious diseases along with antimicrobial resistance. High prevalence of infectious diseases and sexually transmitted diseases (STDs) will continue to drive the future of automated and rapid tests, as the need for quicker, higher volume and more accurate methods of testing gains significance. Emerging technologies and robust processes have thus transcended microbiology testing to the next-level. Rising healthcare expenditure, growing need to speed up microbiological testing, scarcity of time, need for rapid QA-QC procedures, and growing imposition of regulations that regulate various production processes are factors that have catalyzed this transformation. The uptake of microbiology is further favored by technological advancements including automated instruments to identify pathogens across laboratories. Another driver for the market growth is consolidation of laboratories and rising consumer awareness.

Amid the COVID-19 crisis, the global market for Clinical Microbiology Instruments and Reagents estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$5.8 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Instruments, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$2 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.1% CAGR for the next 7-year period. Growth in the Reagents segment is due to increasing aging population that is vulnerable to microbial infections and chronic conditions such as bacterial pneumonia, urinary tract infections, gastrointestinal issues, renal diseases and cancer. The market growth is slated to be augmented by outbreaks of pandemics including COVID-19, Ebola and Zika virus, leaving a large number of infected people.



The U.S. Market is Estimated at $1.6 Billion in 2021, While China is Forecast to Reach $284.1 Million by 2026


The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.6 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$284.1 Million by the year 2026 trailing a CAGR of 7.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR. The US and Europe constitute major markets for automated and rapid microbiological tests. Emerging nations, such as China, India, and Brazil, present significant opportunities due to their constantly growing healthcare infrastructure. Aging population and rising incidence of chronic illnesses and lifestyle diseases are spurring spending on health services and clinical lab services. The Asian market presents substantial growth opportunities owing to rising prevalence of various pathogenic diseases, requirement to accelerate microbiological testing and discovery of adapting and mutating bacterium.

Select Competitors (Total 59 Featured) -

  • 3M
  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biomérieux
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Cepheid Inc
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc
  • NEOGEN Corporation
  • QIAGEN GmbH
  • Hoff Man Roche - Diagnostics Division
  • Shimadzu Corporation
  • Thermo Fisher Scientific
Frequently Asked Questions about the Global Market for Clinical Microbiology Instruments and Reagents

What is the estimated value of the Global Market for Clinical Microbiology Instruments and Reagents?

The Global Market for Clinical Microbiology Instruments and Reagents was estimated to be valued at $4.0 Billion in 2020.

What is the growth rate of the Global Market for Clinical Microbiology Instruments and Reagents?

The growth rate of the Global Market for Clinical Microbiology Instruments and Reagents is 6.4%, with an estimated value of $5.8 Billion by 2026.

What is the forecasted size of the Global Market for Clinical Microbiology Instruments and Reagents?

The Global Market for Clinical Microbiology Instruments and Reagents is estimated to be worth $5.8 Billion by 2026.

Who are the key companies in the Global Market for Clinical Microbiology Instruments and Reagents?

Key companies in the Global Market for Clinical Microbiology Instruments and Reagents include 3M, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux, Bio, Rad Laboratories, Inc, Bruker Corporation and Danaher Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc
  • Cepheid Inc
  • Eiken Chemical Co., Ltd.
  • NEOGEN Corporation

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • The World of Clinical Microbiology Gains Sudden Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: Global Scale of Daily Testing Vs Confirmed Cases Per Million
  • Clinical Microbiology: An Introduction
  • Outlook: Evolutionary Battle against Microbes Drives Market Future
  • Instant Detection of Pathogens : A New Epoch in the Fight for Survival
  • Reagents Account for Major Share
  • Asia-Pacific Drives Future Growth
  • Recent Market Activity
  • World Brands
  • Clinical Microbiology Instruments and Reagents - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Microbiology Laboratories Switch to Automation to Push Yields
  • World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
  • Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
  • Integration of Clinical Microbiology with Cloud Computing
  • Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
  • Advancements in Molecular Diagnostics Drive Market Growth
  • Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
  • Technological Advances Crucial to Sustain Future Market Growth
  • Rapid Diagnostics Bring in a Transformation
  • Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing
  • Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
  • Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing
  • Research in Stem Cell Technology, and Regenerative Medicine Expand Growth Opportunities
  • Stem Cell Banking Global Market Estimates and Forecasts in US$ Billion: 2020, 2022 & 2024
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Home HIV Testing Emerges as a Lucrative Option
  • Increasing Incidence of Infectious Diseases Drives Growth
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Increasing Prevalence of Respiratory Infections Drive Growth
  • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
  • Influenza Boosts Rapid Test Prospects
  • Flu Related CDC Estimates from October 2019-April4, 2020
  • Rise in Prevalence of COPD Augments Demand
  • Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
  • Rise in Pollution Levels Trigger Increase in Respiratory Diseases
  • World Ranking of Most Polluted Countries: 2019
  • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
  • Increase in Healthcare Spending in Emerging Markets to Propel Demand
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Demographic Shifts & Societal Changes Drive Demand for Test Volumes
  • Elderly Healthcare Expenditure as a % of GDP
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Overview
  • Healthcare Spending as a % of GDP in the US: 2010-2020
  • COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests

CANADA

JAPAN

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Overview
  • Covid-19 Testing Market in Japan
  • Demographics Drive Market Growth
  • Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
  • Market Analytics

CHINA

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview
  • Covid-19 Testing Market
  • Market Analytics

EUROPE

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview
  • COVID-19 Pandemic Propels Demand
  • Growth in Clinical Diagnostics Automation
  • Rise in Automated, and Rapid Tests in Clinical Applications
  • Ageing Demography: An Opportunity Indicator
  • Market Analytics

FRANCE

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Market Overview
  • Market Analytics

AUSTRALIA

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Market Overview
  • Private Enterprises Encourage Changes in Diagnostics Sector
  • Market Analytics

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
  • Market Overview

ARGENTINA

BRAZIL

  • Market Overview
  • Market Analytics

MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Clinical Microbiology Instruments and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
  • South Africa
  • Market Analytics

IV. COMPETITION

  • Total Companies Profiled: 59
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3M
  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biomérieux
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Cepheid Inc
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc
  • NEOGEN Corporation
  • QIAGEN GmbH
  • Hoff Man Roche - Diagnostics Division
  • Shimadzu Corporation
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown